Sasol Past Earnings Performance
Past criteria checks 0/6
Sasol has been growing earnings at an average annual rate of 30.4%, while the Chemicals industry saw earnings growing at 9.6% annually. Revenues have been growing at an average rate of 10.2% per year.
Key information
30.4%
Earnings growth rate
30.7%
EPS growth rate
Chemicals Industry Growth | 12.4% |
Revenue growth rate | 10.2% |
Return on equity | -30.0% |
Net Margin | -16.1% |
Next Earnings Update | 24 Feb 2025 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Sasol makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
30 Jun 24 | 275,111 | -44,271 | 45,915 | 0 |
31 Mar 24 | 275,650 | -20,232 | 45,911 | 0 |
31 Dec 23 | 276,189 | 3,806 | 45,907 | 0 |
30 Sep 23 | 282,943 | 6,303 | 44,985 | 0 |
30 Jun 23 | 289,696 | 8,799 | 44,063 | 0 |
31 Mar 23 | 296,162 | 23,677 | 43,095 | 0 |
31 Dec 22 | 302,627 | 38,555 | 42,126 | 0 |
30 Sep 22 | 287,687 | 38,756 | 41,645 | 0 |
30 Jun 22 | 272,746 | 38,956 | 41,164 | 0 |
31 Mar 22 | 251,300 | 24,238 | 41,715 | 0 |
31 Dec 21 | 229,853 | 9,519 | 42,855 | 0 |
30 Sep 21 | 215,882 | 9,276 | 42,041 | 0 |
30 Jun 21 | 201,910 | 9,032 | 40,932 | 0 |
31 Mar 21 | 192,538 | -36,142 | 39,476 | 0 |
31 Dec 20 | 183,165 | -81,316 | 37,725 | 0 |
30 Sep 20 | 186,766 | -86,535 | 38,726 | 0 |
30 Jun 20 | 190,367 | -91,754 | 39,727 | 0 |
31 Mar 20 | 195,085 | -49,980 | 40,953 | 0 |
31 Dec 19 | 199,802 | -6,389 | 42,179 | 0 |
30 Sep 19 | 201,689 | -1,045 | 41,226 | 0 |
01 Jul 19 | 203,576 | 3,389 | 40,272 | 0 |
31 Mar 19 | 199,914 | 10,433 | 39,112 | 0 |
31 Dec 18 | 196,252 | 16,568 | 37,952 | 0 |
30 Sep 18 | 188,857 | 12,649 | 37,165 | 0 |
30 Jun 18 | 181,461 | 8,729 | 36,377 | 0 |
31 Mar 18 | 178,563 | 13,664 | 35,404 | 0 |
31 Dec 17 | 175,665 | 18,599 | 34,431 | 0 |
30 Sep 17 | 174,036 | 19,487 | 33,556 | 0 |
30 Jun 17 | 172,407 | 20,374 | 32,680 | 0 |
31 Mar 17 | 172,885 | 17,482 | 32,389 | 0 |
31 Dec 16 | 173,362 | 14,589 | 32,098 | 0 |
30 Sep 16 | 173,152 | 13,907 | 32,224 | 0 |
30 Jun 16 | 172,942 | 13,225 | 32,350 | 0 |
31 Mar 16 | 171,423 | 15,354 | 33,180 | 0 |
31 Dec 15 | 169,904 | 17,483 | 34,010 | 0 |
30 Sep 15 | 177,585 | 23,600 | 31,908 | 0 |
30 Jun 15 | 185,266 | 29,716 | 29,805 | 0 |
31 Mar 15 | 194,759 | 33,066 | 31,346 | 0 |
31 Dec 14 | 204,252 | 36,415 | 32,887 | 0 |
30 Sep 14 | 203,468 | 32,998 | 34,482 | 0 |
30 Jun 14 | 202,683 | 29,580 | 36,076 | 0 |
31 Mar 14 | 195,496 | 28,204 | 34,037 | 0 |
31 Dec 13 | 188,309 | 26,827 | 31,998 | 0 |
Quality Earnings: SAO is currently unprofitable.
Growing Profit Margin: SAO is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: SAO is unprofitable, but has reduced losses over the past 5 years at a rate of 30.4% per year.
Accelerating Growth: Unable to compare SAO's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: SAO is unprofitable, making it difficult to compare its past year earnings growth to the Chemicals industry (7.2%).
Return on Equity
High ROE: SAO has a negative Return on Equity (-30.01%), as it is currently unprofitable.